These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 15578701)

  • 1. Enhancement of in vitro and in vivo tumor cell radiosensitivity by valproic acid.
    Camphausen K; Cerna D; Scott T; Sproull M; Burgan WE; Cerra MA; Fine H; Tofilon PJ
    Int J Cancer; 2005 Apr; 114(3):380-6. PubMed ID: 15578701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced radiation-induced cell killing and prolongation of gammaH2AX foci expression by the histone deacetylase inhibitor MS-275.
    Camphausen K; Burgan W; Cerra M; Oswald KA; Trepel JB; Lee MJ; Tofilon PJ
    Cancer Res; 2004 Jan; 64(1):316-21. PubMed ID: 14729640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postradiation sensitization of the histone deacetylase inhibitor valproic acid.
    Chinnaiyan P; Cerna D; Burgan WE; Beam K; Williams ES; Camphausen K; Tofilon PJ
    Clin Cancer Res; 2008 Sep; 14(17):5410-5. PubMed ID: 18765532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of xenograft tumor radiosensitivity by the histone deacetylase inhibitor MS-275 and correlation with histone hyperacetylation.
    Camphausen K; Scott T; Sproull M; Tofilon PJ
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6066-71. PubMed ID: 15447991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone deacetylation as a target for radiosensitization.
    Cerna D; Camphausen K; Tofilon PJ
    Curr Top Dev Biol; 2006; 73():173-204. PubMed ID: 16782459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiosensitization by SAHA in experimental colorectal carcinoma models-in vivo effects and relevance of histone acetylation status.
    Folkvord S; Ree AH; Furre T; Halvorsen T; Flatmark K
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):546-52. PubMed ID: 19427556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valproic acid, a histone deacetylase inhibitor, enhances radiosensitivity in esophageal squamous cell carcinoma.
    Shoji M; Ninomiya I; Makino I; Kinoshita J; Nakamura K; Oyama K; Nakagawara H; Fujita H; Tajima H; Takamura H; Kitagawa H; Fushida S; Harada S; Fujimura T; Ohta T
    Int J Oncol; 2012 Jun; 40(6):2140-6. PubMed ID: 22469995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vorinostat enhances the radiosensitivity of a breast cancer brain metastatic cell line grown in vitro and as intracranial xenografts.
    Baschnagel A; Russo A; Burgan WE; Carter D; Beam K; Palmieri D; Steeg PS; Tofilon P; Camphausen K
    Mol Cancer Ther; 2009 Jun; 8(6):1589-95. PubMed ID: 19509253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of valproic acid in DNA double-strand break repair after irradiation in esophageal squamous carcinoma cells.
    Makita N; Ninomiya I; Tsukada T; Okamoto K; Harada S; Nakanuma S; Sakai S; Makino I; Kinoshita J; Hayashi H; Oyama K; Nakagawara H; Miyashita T; Tajima H; Takamura H; Fushida S; Ohta T
    Oncol Rep; 2015 Sep; 34(3):1185-92. PubMed ID: 26135807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Akt by the alkylphospholipid perifosine does not enhance the radiosensitivity of human glioma cells.
    de la Peña L; Burgan WE; Carter DJ; Hollingshead MG; Satyamitra M; Camphausen K; Tofilon PJ
    Mol Cancer Ther; 2006 Jun; 5(6):1504-10. PubMed ID: 16818509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of histone deacetylation: a strategy for tumor radiosensitization.
    Camphausen K; Tofilon PJ
    J Clin Oncol; 2007 Sep; 25(26):4051-6. PubMed ID: 17827453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isotype-Specific Inhibition of Histone Deacetylases: Identification of Optimal Targets for Radiosensitization.
    Kim JH; Moon SH; No M; Kim JJ; Choi EJ; Cho BJ; Kim JS; Kim IH; Kim IA
    Cancer Res Treat; 2016 Jul; 48(3):1130-40. PubMed ID: 26582395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity.
    Munshi A; Kurland JF; Nishikawa T; Tanaka T; Hobbs ML; Tucker SL; Ismail S; Stevens C; Meyn RE
    Clin Cancer Res; 2005 Jul; 11(13):4912-22. PubMed ID: 16000590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo radiosensitization induced by the DNA methylating agent temozolomide.
    Kil WJ; Cerna D; Burgan WE; Beam K; Carter D; Steeg PS; Tofilon PJ; Camphausen K
    Clin Cancer Res; 2008 Feb; 14(3):931-8. PubMed ID: 18245557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The DNA-PK Inhibitor VX-984 Enhances the Radiosensitivity of Glioblastoma Cells Grown
    Timme CR; Rath BH; O'Neill JW; Camphausen K; Tofilon PJ
    Mol Cancer Ther; 2018 Jun; 17(6):1207-1216. PubMed ID: 29549168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor.
    Petersen C; Petersen S; Milas L; Lang FF; Tofilon PJ
    Clin Cancer Res; 2000 Jun; 6(6):2513-20. PubMed ID: 10873107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiosensitivity enhancement of human thyroid carcinoma cells by the inhibitors of histone deacetylase sodium butyrate and valproic acid.
    Perona M; Thomasz L; Rossich L; Rodriguez C; Pisarev MA; Rosemblit C; Cremaschi GA; Dagrosa MA; Juvenal GJ
    Mol Cell Endocrinol; 2018 Dec; 478():141-150. PubMed ID: 30125607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of valproic acid on radiation-induced DNA damage in euchromatic and heterochromatic compartments.
    Harikrishnan KN; Karagiannis TC; Chow MZ; El-Osta A
    Cell Cycle; 2008 Feb; 7(4):468-76. PubMed ID: 18239454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the Histone H3K27 Demethylase UTX Enhances Tumor Cell Radiosensitivity.
    Rath BH; Waung I; Camphausen K; Tofilon PJ
    Mol Cancer Ther; 2018 May; 17(5):1070-1078. PubMed ID: 29483212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic therapy using the histone deacetylase inhibitor for increasing therapeutic gain in oral cancer: prevention of radiation-induced oral mucositis and inhibition of chemical-induced oral carcinogenesis.
    Chung YL; Lee MY; Pui NN
    Carcinogenesis; 2009 Aug; 30(8):1387-97. PubMed ID: 19351790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.